Intraventricular neurocysticercosis managed with albendazole and dexamethasone.
Hajek
Jan
J
Division of Infectious Diseases, North York General Hospital, Canada. jan.hajek@utoronto.ca
Keystone
Jay
J
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods; D008590:Meningoencephalitis / Q000175:diagnosis / Q000188:drug therapy*; D020019:Neurocysticercosis / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed / Q000379:methods
D000893:Anti-Inflammatory Agents; D000981:Antiprotozoal Agents; D003907:Dexamethasone; D015766:Albendazole